Delusional misidentification in association with parkinsonism.
The delusional misidentification syndrome (DMS) has been associated with a range of neurological conditions. Three cases of DMS in patients with Parkinson's disease and dementia, treated with dopaminergic medications, are presented. It is postulated that DMS associated with parkinsonism results from a combination of dopaminergic psychosis and cognitive dysfunction involving the frontal lobe in particular. DMS in the setting of parkinsonism may be more frequent than commonly supposed.
Roane
D M
DM
Department of Psychiatry, Beth Israel Medical Center, New York, New York 10003, USA.
Rogers
J D
JD
Robinson
J H
JH
Feinberg
T E
TE
D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002194:Capgras Syndrome / Q000139:chemically induced / Q000150:complications* / Q000188:drug therapy; D003024:Clozapine / Q000627:therapeutic use; D003702:Delusions / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy; D005260:Female; D006212:Hallucinations / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D003024:Clozapine